We are live on ! Find out more
DNTH icon

Dianthus Therapeutics

74 hedge funds and large institutions have $437M invested in Dianthus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

52% more capital invested

Capital invested by funds: $288M → $437M (+$149M)

50% more call options, than puts

Call options by funds: $3K | Put options by funds: $2K

3% more funds holding

Funds holding: 7274 (+2)

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

0.1% more ownership

Funds ownership: 4.52%4.62% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.46%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
17
Increased
19
Reduced
18
Closed
10
Calls
$3K
Puts
$2K
Net Calls
+$1K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
AA
76
ALPS Advisors
Colorado
-$793K -4,833 Closed
BCM
77
BlueCrest Capital Management
Jersey
-$410K -2,500 Closed
VEA
78
Virtus ETF Advisers
New York
-$181K -1,100 Closed
AG
79
Algert Global
California
-$129K -784 Closed
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
-$109K -664 Closed
OAM
81
Oxford Asset Management
United Kingdom
-$103K -630 Closed
UBS Group
82
UBS Group
Switzerland
-$92K -562 Closed
Victory Capital Management
83
Victory Capital Management
Texas
-$31K -187 Closed
MAM
84
Meeder Asset Management
Ohio
-$1K -8 Closed